Furthermore, the most effective therapeutic agents for Alzheimer's disease, such as the anti-acetylcholinesterase drug galantamine, also target the α7-nAChR [17]–[18]. The gene discussed is CHRNA7; the disease is early-onset autosomal dominant Alzheimer disease.